Skip to main content
BIONIME logo

BIONIME — Investor Relations & Filings

Ticker · 4737 ISIN · TW0004737002 TW Manufacturing
Open in API
Filings indexed 1,735 across all filing types
Latest filing 2023-09-08 Regulatory Filings
Country TW Taiwan
Listing TW 4737

About BIONIME

www.bionime.com

Bionime Corporation is a biotechnology firm specializing in the research, design, and manufacturing of comprehensive blood glucose management systems. The company develops high-precision monitoring solutions for both personal home use and professional medical environments, including Blood Glucose Meters (BGM), Continuous Glucose Monitoring Systems (CGM), and Point-of-Care Testing (POCT). Under its proprietary brand, RIGHTEST, Bionime integrates medical, chemical, electronic, and precision machinery expertise to deliver products that rival international standards. A core component of its offering is a cloud-based management ecosystem powered by IoT digital solutions, which synchronizes medical data with patient care services. With over 480 core patents in CGM technology and a commitment to Industry 4.0 smart production, Bionime focuses on enhancing diabetes care through technical innovation and a human-centered approach to health monitoring.

Recent filings

Filing Released Lang Actions
112年8月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company (華廣) regarding the status of fund loans and endorsement guarantees for the current and previous month, including cumulative amounts and limits. It contains no detailed financial statements, management discussion, or comprehensive report content. The length is very short (601 characters), and it primarily provides regulatory compliance information about financial guarantees and loans. This type of document fits best under Regulatory Filings (RNS), as it is a general regulatory announcement without substantive financial report data or analysis.
2023-09-08 Chinese
112年8月營業收入
Regulatory Filings Classification · 90% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 華廣, presented in a tabular format with explanations about accounting standards and reporting practices. It contains no detailed financial statements, management discussion, or comprehensive analysis. The length is short (777 characters), and it appears to be a regulatory or public disclosure of revenue figures rather than a full financial report or earnings release. There is no indication of an earnings announcement or detailed quarterly report, nor is it a notice of dividend, capital change, or management change. The document is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement of financial data without the depth or format of a formal financial report or earnings release.
2023-09-08 Chinese
112年08月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tabular data about shareholdings and pledged shares of company insiders, including directors, independent directors, and senior management. It lists current holdings, pledged shares, and related percentages. The content focuses on insider shareholdings and pledges rather than financial results, management changes, or meeting materials. There is no indication of a report publication, earnings release, or regulatory certification. The document is a notification of insider shareholdings and pledges, which aligns with the category of Director's Dealing (DIRS), as it reports personal share transactions or holdings by company directors and executives. The document length is 3197 characters, which is consistent with a detailed insider shareholding report rather than a full financial report or announcement. Therefore, the most appropriate classification is DIRS.
2023-09-05 Chinese
112年08月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings of insiders, including directors, managers, and their related parties. It shows the number of shares held, increases, decreases, and other shareholding details for various insiders. This type of document is typical of a Director's Dealing report, which discloses personal share transactions by company directors and executives. There is no indication of financial statements, earnings data, or meeting materials. The document is not an announcement of a report but contains substantive data on insider shareholdings. Therefore, the appropriate classification is Director's Dealing (DIRS).
2023-09-05 Chinese
公告本公司業務處主管異動
Board/Management Information Classification · 100% confidence The document is a short announcement (694 characters) about a change in a company's business department head, specifically mentioning the resignation of a business unit supervisor and the effective date. It includes details about the old and new personnel and the reason for the change. There is no financial data, no mention of financial results, reports, or regulatory filings beyond this personnel change. This fits the definition of Board/Management Information (MANG), which covers announcements of changes in senior management or company officers.
2023-08-18 Chinese
112年第2季海外子公司投資
Regulatory Filings Classification · 90% confidence The document contains detailed financial data about investments in overseas subsidiaries, including shareholding percentages, original investment amounts, investment balances, and recognized investment gains or losses for the current period. The data is presented in a tabular format with notes explaining accounting treatments, consistent with equity method investment disclosures. The document length is only 1005 characters, which is quite short and does not appear to be a full financial report like an Annual Report (10-K) or Interim Report (IR). It also does not resemble an announcement or notice but rather a financial data disclosure. Given the nature of the content focusing on investment accounting details and the short length, it is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories and often include such investment disclosures in regulatory filings in Taiwan.
2023-08-11 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.